Current Information and Recommendations on the Discontinuation of TKI Inhibitors in Chronic Myeloid Leukemia
Current Oncology Reports - United States
doi 10.1007/s11912-018-0669-y
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2018
Authors
Publisher
Springer Science and Business Media LLC